Phase 3 Dexmedetomidine Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block
Erector Spinae BlockDexmedetomidine
Aswan University75 enrolled1 locationNCT06386770
Recruiting
Phase 3
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
DexmedetomidineFentanyl
Aswan University148 enrolled1 locationNCT06386783
Recruiting
Phase 3
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Retinopathy of PrematurityDexmedetomidine
Assaf-Harofeh Medical Center30 enrolled1 locationNCT06067958
Terminated
Phase 3
Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy
Safety and Feasibility of Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy
Keat Lee100 enrolled1 locationACTRN12608000304336